Stay updated on Elunate® Phase IV Study in Chinese Patients Clinical Trial
Sign up to get notified when there's something new on the Elunate® Phase IV Study in Chinese Patients Clinical Trial page.

Latest updates to the Elunate® Phase IV Study in Chinese Patients Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.2%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed descriptions of a clinical study on Elunate® (Fruquintinib) and the addition of a new revision number. The mention of 'Patient Safety' has been added, indicating a potential shift in focus.SummaryDifference14%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.2%
- Check81 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference3%
- Check96 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference3%
- Check103 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.2%
Stay in the know with updates to Elunate® Phase IV Study in Chinese Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elunate® Phase IV Study in Chinese Patients Clinical Trial page.